Radial Extracorporeal Shock Wave Therapy Versus Platelet-rich Plasma Injection for Greater Trochanteric Pain Syndrome

I

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Status

Completed

Conditions

Gluteal Tendinopathy
Greater Trochanteric Pain Syndrome

Treatments

Procedure: rESWT
Procedure: PRP injection

Study type

Interventional

Funder types

Other

Identifiers

NCT04537091
2020-309

Details and patient eligibility

About

Greater trochanteric pain syndrome (GTPS), is characterised by pain around the greater trochanter. Failure of first-line management for GTPS is followed by second-line treatments range from extracorporeal shock wave therapy (ESWT), corticosteroid or platelet-rich plasma (PRP) injections, and surgery. In a systematic reviews, PRP seems a viable effective and safe alternative option for GTPS after failed physical therapy. Also, positive results from previous systematic reviews involving radial ESWT (rESWT) as a treatment for GTPS. In the literature review, there is no comparison of the effectiveness of ESWT and PRP injection in patients with GTPS. The aim of this study was to investigate the effects of rESWT and PRP injection on pain, hip disability, and quality of life in patients with GTPS

Full description

The pain and activities of daily living, referring to the previous week, and assessments of hip function (limping) and range of motion were evaluted by Harris Hip Score (HHS). The pain severity during rest and activity in the previous week was evaluted by Visual Analog Scale (VAS). The pain and activity limitation was evaluted by The Roles and maudsley (RM). The quality of life was evaluted by The EQ-5D-3L scale.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • > 18 years old
  • Complaining of pain located anterior, lateral or posterior to the great trochanter for more than 3 months
  • Pain while lying on the affected side
  • Local tenderness on palpation of the area of the great trochanter
  • MRI evidence of gluteus minimus or medius tendinopathy
  • Refractory to conservative management

Exclusion criteria

  • Presence of signs and symptoms of another cause of regional hip pain.
  • Full-thickness tear of the involved gluteal tendons, bursa, and intra-articular structures
  • Evidence of concomitant injury to the involved lower extremity, including radiculopathy or radiculitis, ischial tuberosity avulsion
  • Severe knee or hip osteoarthritis
  • Previous hip surgery or use of ESWT for GTPS.
  • Acute low back pain
  • Implanted pacemaker
  • Vascular, neurologic, rheumatic diseases.
  • Any neoplastic disorders
  • Blood coagulation disorders or use of antiplatelet or anticoagulant drugs
  • Pregnancy.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

30 participants in 2 patient groups

ESWT group: rESWT
Experimental group
Description:
rESWT treatment was applied to patients
Treatment:
Procedure: rESWT
PRP group: PRP injection
Experimental group
Description:
PRP treatment was applied to patients
Treatment:
Procedure: PRP injection

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems